STOCK TITAN

OrganiGram Holdings Inc. - OGI STOCK NEWS

Welcome to our dedicated news page for OrganiGram Holdings (Ticker: OGI), a resource for investors and traders seeking the latest updates and insights on OrganiGram Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect OrganiGram Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of OrganiGram Holdings's position in the market.

Rhea-AI Summary
Organigram Holdings Inc. (NASDAQ: OGI) has been recognized on the 2024 Report on Business 'Women Lead Here' list for gender diversity, with 50% of its executive leadership team being women. The company stands out in the cannabis industry for its significant female leadership presence. Organigram prioritizes inclusivity, flexibility, and equality in the corporate landscape, with over 46% of its workforce being women.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.83%
Tags
none
-
Rhea-AI Summary
Organigram Holdings Inc. celebrates SHRED brand's success, surpassing $200 million in yearly retail sales with innovative products that revolutionized the cannabis industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.25%
Tags
none
-
Rhea-AI Summary
Organigram Holdings Inc. successfully closes a public offering, raising C$28.8 million in gross proceeds to enhance its balance sheet. The Company sold 8,901,000 Units at C$3.23 per Unit, including the exercise of the over-allotment option. Each Unit comprises a Common Share and a Warrant. The net proceeds will be used for growth initiatives and general corporate purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.97%
Tags
Rhea-AI Summary
Organigram Holdings Inc. announces a public offering of units, led by ATB Securities Inc., to sell 7,740,000 Units at C$3.23 per Unit, aiming to raise approximately C$25 million. The Company grants underwriters an over-allotment option to purchase up to an additional 1,161,000 Units. Each Unit includes a Common Share and a Warrant, with the Warrant exercisable at C$3.65 per share for four years post-closing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.37%
Tags
-
Rhea-AI Summary
Organigram Holdings Inc. announces a public offering of units for gross proceeds of approximately C$25 million. The offering will be completed through underwriting agreements with ATB Securities Inc. and is expected to close on April 2, 2024. The company plans to use the net proceeds for growth initiatives, acquisitions, and investments in the cannabis and hemp markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.37%
Tags
-
Rhea-AI Summary
Organigram Holdings Inc. (OGI) announces a $2 million minority investment in Open Book Extracts, a leading hemp-derived extracts and products provider. The investment aims to expand Organigram's footprint in the U.S. market and explore potential product launches, research collaborations, and international opportunities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.35%
Tags
none
Rhea-AI Summary
Organigram Holdings Inc. announced that Health Canada has reclassified its Edison Jolts lozenge products as edible cannabis despite evidence supporting ingestible classification. The decision follows a court ruling on procedural fairness. Organigram is disappointed and is evaluating next steps.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.35%
Tags
none
-
Rhea-AI Summary
Organigram Holdings Inc. supports the Standing Committee on Finance's recommendation to adjust the excise duty framework for the cannabis industry. Licensed producers currently pay up to 35% of revenue in excise duties, hindering competitiveness and innovation. The proposed 10% ad valorem rate reduction could significantly benefit the sector's sustainability and support government objectives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.09%
Tags
none
-
Rhea-AI Summary
Organigram Holdings Inc. achieved positive cash flow and solidified its market position in Canada, announcing a $124.6 million strategic investment from BAT. They improved margins, maintained market positions, and introduced new products. Despite a decline in net revenue, the company showed positive Adjusted EBITDA and cash flow. Key financial metrics and balance sheet data highlight the company's financial standing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.55%
Tags
Rhea-AI Summary
Organigram Holdings Inc. (OGI) will report earnings for its first quarter fiscal 2024 on February 13, 2024. The conference call to discuss the results will be held at 8:00 am Eastern Time on the same day. The registration link for the call and webcast details are provided in the press release.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.69%
Tags
conferences earnings
OrganiGram Holdings Inc.

Nasdaq:OGI

OGI Rankings

OGI Stock Data

192.90M
65.94M
34.74%
11.2%
3.77%
Medicinal and Botanical Manufacturing
Manufacturing
Link
Canada
Toronto

About OGI

as part of canada’s marihuana for medical purposes regulations (mmpr), organigram (tsx-v:ogi) is atlantic canada's original licensed producer of medical marijuana. we are dedicated to consistently providing our clients with the highest quality, organically grown medicine and service. if you have questions or want to learn more, visit www.organigram.ca or give our client services team a call at 1-855-961-9420.